Condition
Adenovirus clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Adenovirus clinical trials that are recruiting, at sites in 2 countries (most in United States (7), Cambodia (1)). By phase: Phase 1 (2), Phase 2 (2), Phase 1/2 (1), Phase 3 (1). The most active sponsors are Columbia University (2), New York Medical College (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 2Countries
Newest Adenovirus clinical trials
All recruiting trials (8)
-
Community spread of multiple infectious diseases in Cambodia from a One Health perspective
This project will test how common and connected dengue, chikungunya, Zika, Japanese encephalitis, and West Nile infections are among people, animals, and the environment across Cambodia.
-
Family-donor viral CTLs plus standard care vs standard care alone for refractory ADV or CMV infection after stem cell transplant
This study tests whether using family-donor virus-specific CTLs in addition to usual treatment helps children, teens, and young adults with hard-to-treat CMV or adenovirus infections after a stem cell transplant.
-
R-MVST cell therapy for viral infections in children and young adults
This will try giving rapidly generated virus-specific T cells (R-MVST) to children and young adults whose weakened immune systems have recurrent or treatment-resistant infections with EBV, CMV, adenovirus, or BK virus.
-
Partially HLA-matched virus-specific T-cell therapy for adenovirus, CMV, or EBV in immunocompromised patients
This will try partially matched virus-specific T cells to treat adenovirus, CMV, or EBV infections in people whose immune systems are weakened after stem-cell or organ transplants or other immunodeficiencies.
-
Using donor T-cells to treat viral infections after stem cell transplantation
This study is testing if special immune cells from related donors can help patients who had a stem cell transplant fight off viral infections like CMV and ADV.
-
Treatment of viral infections using rapidly generated T cells
This study is testing a new treatment using specially made T cells to help patients with weakened immune systems who are struggling with serious viral infections like Epstein-Barr or cytomegalovirus.
-
Donor-derived virus-specific T cell therapy for CMV or adenovirus after organ or stem-cell transplant
This tests donor-derived virus-specific T cells to treat CMV or adenovirus reactivation in people who have had a solid organ or stem-cell transplant.
-
Using specialized T-cells to treat adenovirus infections in patients with immune deficiencies
This study is testing whether special T-cells can help children, teens, and young adults with weak immune systems who have ongoing adenovirus infections after organ transplants.
Related topics
Quick answers
How many Adenovirus clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (7 trials), Cambodia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 2, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.